1. 964PPreoperative c-reactive protein and thrombocyte count as potential markers for longterm survival in ovarian cancer. (23rd October 2018) Authors: Braicu, E I; Sehouli, J; Richter, R; Vergote, I B; Concin, N; van Nieuwenhuysen, E; Achimas, P; Berger, A; Fetica, B; Mahner, S; Glajzer, J; Papadia, A; Woelber, L; Gasparri, M L; Vanderstichele, A; Benedetti Panici, P; Mueller, M; Ruscito, I; Zimmer, J; Woopen, H Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P115 Quality-of-life analysis in the randomized phase II CLIO trial comparing olaparib with standard chemotherapy in platinum-resistant recurrent ovarian cancer. (1st November 2019) Authors: Callewaert, T; Vanderstichele, A; Van Nieuwenhuysen, E; Han, S; Concin, N; Van Gorp, T; Berteloot, P; Neven, P; Busschaert, P; Lambrechts, D; Vergote, I Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. TP53 mutations in cell-free DNA as early markers of therapeutic response in platinum-resistant relapsed ovarian cancer (PROC): a prospective translational analysis of the phase II GANNET53 clinical trial. (1st November 2019) Authors: Vanderstichele, A; Concin, N; Busschaert, P; Braicu, I; Combe, P; Ray-Coquard, I; Joly, F; Harter, P; Wimberger, P; Selle, F; Ignatov, A; Schmalfeldt, B; Van Nieuwenhuysen, E; Darb-Esfahani, S; Zeimet, A; Mahner, S; Pujade-Lauraine, E; Marth, C; Berger, R; Sehouli, J Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗